The Canadian Breast Cancer Foundation (CBCF) is a national community-driven charity. As the largest charitable funder of breast cancer research in Canada, CBCF’s vision is to create a future without breast cancer. Since its inception in 1986, the Foundation has invested over $360 million in breast cancer research, funding more than 1,400 scientific and community grants. CBCF’s investments in vital research, education, health promotion, support and information programs have led to progress in breast cancer prevention, diagnosis, treatment and care.
Other Research Grants
Dr. Sheila Drover, Associate Professor of Immunology in the Faculty of Medicine at Memorial University in St. John, NL, specializes in cancer immunity: finding new ways to help the body recognize and destroy its own cancer cells. Read more
Screening mammography is the best tool for the early detection of breast cancer. However, the British Columbia screening mammography rate is still below the national target of 70 per cent. Read more
Caregivers of breast cancer patients play a vital role. For male partners of women with breast cancer, research has shown that the demands of this responsibility can have a significant impact on their psychological well being. Read more
This is the question that Dr. Wendy Parulekar, from Queen’s University, and an international team of researchers are trying to answer. Since 2011, CBCF – Ontario has invested almost $900,000 in a large international trial of over 3,500 patients to determine whether metformin – a safe and inexpensive drug long used to treat type II diabetes – can reduce breast cancer recurrence and improve survival in women with early-stage breast cancer. Read more
Triple-negative breast cancer is a difficult-to-treat form of the disease that often has a poor prognosis, due to its aggressive nature and tendency to relapse and metastasize (spread). Although chemotherapy is the treatment of choice, these drugs may cause secondary cancers to develop, and they also have harmful side effects. Read more
Triple-negative breast cancer (TNBC) is an aggressive cancer that occurs globally in 400,000 women each year, often affecting younger people. It is much more aggressive than other cancers and is more likely to relapse and spread. A discovery made by a Canadian Breast Cancer Foundation – BC/Yukon Region funded research project has identified a protein critical to the survival of TNBC patients. Read more